O ROURKE & COMPANY Inc Cuts Stock Position in iShares Biotechnology ETF $IBB

O ROURKE & COMPANY Inc cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,509 shares of the financial services provider’s stock after selling 216 shares during the quarter. O ROURKE & COMPANY Inc’s holdings in iShares Biotechnology ETF were worth $823,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ramirez Asset Management Inc. purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $26,000. Financial Gravity Asset Management Inc. purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $30,000. Woodside Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $31,000. CX Institutional purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $32,000. Finally, Garde Capital Inc. purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $36,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

IBB stock opened at $144.37 on Wednesday. The firm has a fifty day moving average price of $138.33 and a 200 day moving average price of $129.66. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.04.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.